Target intelligence / Profile preview

Human immunodeficiency virus 1 ribonucleic acid (HIV-1 RNA)

Target
HIV-1 RNA
Molecular classification
Nucleic acid, Viral genome, Ribonucleic acid
01

Overview

Human immunodeficiency virus 1 ribonucleic acid (HIV-1 RNA) is the genetic material of the HIV-1 virus, consisting of two identical single-stranded, positive-sense RNA molecules. It serves as the primary template for reverse transcription into double-stranded DNA by the viral enzyme reverse transcriptase, a critical step for the integration of the viral genome into the host cell's DNA. Beyond its role as a genetic template, HIV-1 RNA functions as messenger RNA (mRNA) for the synthesis of viral polyproteins and contains complex secondary structures, such as the Trans-activation response (TAR) element and the Rev response element (RRE), which regulate viral replication and nuclear export. In clinical practice, HIV-1 RNA is the definitive biomarker for monitoring viral load and assessing the efficacy of antiretroviral therapy (ART). While traditional drugs target the proteins encoded by the RNA, such as reverse transcriptase and protease, modern therapeutic strategies are exploring the direct targeting of the RNA itself using antisense oligonucleotides and RNA interference to silence viral gene expression and deplete the latent viral reservoir.

Other names
HIV-1 genomeHIV-1 genomic RNAHIV-1 transcriptvRNA
02

Mechanism of action

Inhibition of reverse transcription (RNA-dependent DNA polymerase activity), RNA interference (experimental), Antisense inhibition (experimental), and Ribonuclease H-mediated degradation.

03

Biological functions

Genetic information storageTemplate for reverse transcriptionTemplate for translationViral packagingRegulation of viral gene expression
04

Disease associations

InfectionAcquired immunodeficiency syndrome (AIDS)
05

Safety considerations

High mutation rate leading to drug resistanceOff-target effects of RNA-targeting therapeuticsIntegration into host genome (as proviral DNA)Persistent viral reservoirs
06

Interacting drugs

Tenofovir disoproxil fumarate

5 more in the full profile.

07

Biomarkers

Plasma HIV-1 RNA (Viral load)Cell-associated HIV-1 RNA

Beyond the preview

Go deeper on Human immunodeficiency virus 1 ribonucleic acid (HIV-1 RNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human immunodeficiency virus 1 ribonucleic acid (HIV-1 RNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call